|
Castellano-Castillo D, Nunez-Sanchez MA, Balaguer-Roman A, Martinez-Sanchez MA, Fernandez-Ruiz VE, Ferrer-Gomez M, Martinez CM, Frutos MD, Queipo-Ortuno MI, Cardona F, Ramos-Molina B. The role of PCSK9 in metabolic dysfunction-associated steatotic liver disease and its impact on bariatric surgery outcomes. Surg Obes Relat Dis. 2024 Jul;20(7):652-659. doi: 10.1016/j.soard.2024.01.017. Epub 2024 Feb 6. PubMed PMID: 38490825.
AÑO: 2024; IF: 3.5
|
38490825
|
Martinez-Montoro JI, Martinez-Sanchez MA, Balaguer-Roman A, Fernandez-Ruiz VE, Hernandez-Barcelo JE, Ferrer-Gomez M, Frutos MD, Nunez-Sanchez MA, Fernandez-Garcia JC, Ramos-Molina B. Triglyceride to HDL Cholesterol Ratio for the Identification of MASLD in Obesity: A Liver Biopsy-Based Case-Control Study. Nutrients. 2024 Apr 27;16(9):1310. doi: 10.3390/nu16091310. PubMed PMID: 38732557; PubMed Central PMCID: PMC11085202.
AÑO: 2024; IF: 4.8
|
|
Nunez-Sanchez MA, Martinez-Sanchez MA, Sierra-Cruz M, Lambertos A, Rico-Chazarra S, Oliva-Bolarin A, Balaguer-Roman A, Yuste JE, Martinez CM, Mika A, Frutos MD, Llamoza-Torres CJ, Cordoba-Chacon J, Ramos-Molina B. Increased hepatic putrescine levels as a new potential factor related to the progression of metabolic dysfunction-associated steatotic liver disease. J Pathol. 2024 Sep;264(1):101-111. doi: 10.1002/path.6330. Epub 2024 Jul 18. PubMed PMID: 39022853; PubMed Central PMCID: PMC11300153.
AÑO: 2024; IF: 5.6
|
|
Perez-Diaz AJ, Ros-Madrid I, Martinez-Sanchez MA, Rico-Chazarra S, Oliva-Bolarin A, Balaguer-Roman A, Fernandez-Ruiz VE, Martinez CM, Yuste JE, Ferrer-Gomez M, Llamoza-Torres CJ, Frutos MD, Nunez-Sanchez MA, Ramos-Molina B. Alterations in hepatic amino acid metabolism related to MASLD in individuals with obesity. J Physiol Biochem. 2025 May 8. doi: 10.1007/s13105-025-01086-7. Online ahead of print. PubMed PMID: 40335876.
AÑO: 2025; IF: 3.7
|